Background
Nasopharyngeal carcinoma (NPC) is an aggressive type of head and neck malignancy arising from nasopharyngeal epithelium [
1]. Currently, NPC patients are still suffering from the unsatisfactory 5-year survival rate which is around 50–70% [
2]. In particular, incidence of NPC is the highest in China, and NPC patients in China are becoming younger in average age [
3]. NPC progression is known to be deeply associated with genetic and epigenetic abnormalities [
4]. Hence, better elucidating of molecular mechanism underlying NPC development is helpful to explore the potential strategies for NPC patients.
Long non-coding RNAs (lncRNAs) are characterized as a set of non-coding RNAs (ncRNAs) with more than 200 nucleotides in length [
5]. Large numbers of studies have delineated that lncRNAs function as oncogenes or tumor suppressors in human cancer development [
6]. Furthermore, numerous lncRNAs have been reported in NPC progression. For example, lncRNA AFAP1-AS1 regulated miR-423-5p/Rho/Rac axis to aggravate NPC metastasis [
7]. LncRNA UCA1 aggravated proliferation, migration and invasion of NPC cells through regulating miR-145 [
8]. In this study, we aimed to explore the role of a novel functional lncRNA in NPC. LncRNA MSC antisense RNA 1 (MSC-AS1), with a length of 4802 bp, was reported to indicate poor recurrence-free survival in hepatocellular carcinoma (HCC) [
9], function as a tumor facilitator in pancreatic cancer [
10], and regulate osteogenic differentiation [
11]. Through GEPIA (
http://gepia.cancer-pku.cn/), lncRNA MSC-AS1 was highly expressed in head and neck squamous cell carcinoma (HNSC) samples and associated with poor overall survival of patients. Owing to NPC is a kind of head and neck cancer [
7,
12,
13], we explored whether MSC-AS1 is associated with the progression of NPC.
MicroRNAs (miRNAs) are another group of ncRNAs with about 22 nucleotides. MiRNAs are recognized as the essential modulators of gene expression by base-pairing to mRNAs
14]. Researchers have indicated the correlation of miRNAs with NPC progression [
15,
16]. Notably, plentiful reports have demonstrated the competitive endogenous RNA (ceRNA) mechanism in NPC. The ceRNA mechanism is that lncRNAs function as miRNA sponges to increase the expression of miRNAs’ downstream genes. For example, lncRNA PCAT7 upregulated ELF2 by sponging miR-134-5p to promote tumor growth in NPC [
17]; lncRNA SNHG7 regulated miR-145a-5p/NUAK1 axis to drive metastasis and invasion in NPC [
18]. In our current study, bioinformatics analysis and RT-qPCR examination revealed the highest binding potential of miRNA with MSC-AS1. MiR-524-5p, with a length of 22 nucleotides, has been reported to possess anti-tumor function in multiple cancers, such as pituitary tumor [
19], gastric cancer [
20], melanoma [
21] and glioma [
22]. However, its interaction with MSC-AS1 in NPC has never been explored. In this study, we demonstrated the interaction between MSC-AS1 and miR-524-5p through mechanism investigation and functions of miR-524-5p was disclosed by gain-of-function assays.
Nuclear receptor subfamily 4 group A member 2 (NR4A2) belongs to the NR subfamily 4 group A (NR4A) family which is characterized as a group of immediate-early genes activated by growth factors, mitogens, or other stimuli [
23]. Accumulating researches stated that NR4A2 played an oncogenic role in cancers [
24‐
27]. For example, NR4A2 suppressed p53 transactivation to save cells from p53-induced apoptosis [
28]. NR4A2 upregulation induced cell growth in cervical cancer and activation of Notch signaling silenced NR4A2 to repress cervical cancer progression [
29]. In NPC, it has been reported that high cytoplasmic NR4A2 expression predicted poor prognosis in NPC [
30]. However, association of NR4A2 with MSC-AS1 and miR-524-5p has never been revealed in NPC.
Therefore, the purpose of this study is to uncover the impact and mechanism of MSC-AS1 in NPC.
Materials and methods
Tissue collection
Between June 2013 and April 2018, amount to 34 pairs of NPC tissues and pair-matched adjacent normal tissues were collected from patients who underwent surgical resection at The Second Affiliated Hospital of Harbin Medical University. Before surgery, patients who received radiotherapy and chemotherapy were excluded. After resection, the coupled tissues were immediately preserved at -80 °C. Ethical approval was obtained from the ethics committee of The Second Affiliated Hospital of Harbin Medical University. All patients for participation provided informed consent.
Cell culture
Two nasopharyngeal epithelial cells (NP69 and NP460) and four nasopharyngeal carcinoma (NPC) cells (SUNE1, CNE-2, 5-8F, CNE-1) were obtained from the Chinese Academy of Sciences (Shanghai, China). All cells were incubated in RPMI-1640 medium (Gibco, Rockville, MD, USA) containing 10% fetal bovine serum (FBS; Gibco). Cells were incubated under the standard environment (37 °C, 5% CO2).
Cell transfection
At 1day prior to transfection, 5-8F or CNE-1 cells were incubated in six-well plates. Then, cells were transfected via Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA). Short hairpin RNA (shRNA) targeting MSC-AS1 (sh-MSC-AS1#1/2) and the negative control (sh-NC), miR-23b-3p mimic, miR-524-5p mimic/inhibitor, NC mimic/inhibitor, along with the overexpression of NR4A2, MSC-AS1 and pcDNA3.1 empty vector were constructed from RiboBio (Guangzhou, China). Transfection took place after 48 h, and cells were all harvested. The sequences were shown in Additional file
1: Table S1.
RNA extraction and RT-qPCR analysis
Total RNA was extracted using TRIzol reagent (Invitrogen), and then the PrimeScript reverse transcriptase reagent kit (Takara, Kusatsu, Japan) was applied to synthesize cDNA. Real-time PCR amplification was then performed using an SYBR Green Real-Time PCR Kit (Applied Biosystems, Foster City, CA, USA) on the Bio-Rad CFX96 System (Applied Biosystems). As the endogenous control, U6/GAPDH was used. The 2
-ΔΔCT method was selected for transcript quantification. The primers were listed in Additional file
1: Table S1.
CCK-8 assay
5-8F or CNE-1 cells were seeded in 96-well plates and incubated at different periods. Each well in fresh medium was added by 10 µl of CCK-8 solution and incubated for 4 h continually. Finally, the absorbance at OD value (450 nm) was assessed through a microplate reader (Bio-Rad, Hercules, CA, USA).
Transfected 5-8F or CNE-1 cells were placed into six-well plates and maintained in medium added with 10% FBS (Gibco). Rinsed through ice-cold PBS (Sigma-Aldrich, St. Louis, MO, USA), colonies were subsequently fixed through methanol (Sigma-Aldrich), dyed using crystal violet (Sigma-Aldrich) and then counted manually.
EdU assay
5 × 104 transfected cells of 5-8F or CNE-1 were plated into the each well of 96-well plates, and then 100 μL of EdU medium was added for 3 h. The proliferative cells were detected using EdU assay kit (Ribobio) as per instruction. Cells were fixed by 4% paraformaldehyde, permeabilized by 0.5% Troxin X-100 and incubated in 1 × Apollo® 488 staining solution. After DAPI staining (0.3 mM; Sigma-Aldrich) for nuclear detection, cell samples were assayed using fluorescence microscope (Leica, Mannheim, Germany).
Caspase-3 activity assay
Using Beyotime C1115 Caspase 3 Activity Assay Kit (Beyotime, Nantong, China), the activity of caspase-3 was determined. Isolated proteins from transfected 5-8F or CNE-1 cells were added into 96-well plates with the reaction buffer (Invitrogen). Finally, caspase-3 activity was examined through a microplate reader (Thermo Fisher Scientific) at 405 nm.
Tunel assay
Transfected 5-8F or CNE-1 cells were incubated with fluorescein-labelled dUTP (Thermo Fisher Scientific). After that, the nucleus was stained by 0.3 mM of DAPI from Sigma-Aldrich. Through the fluorescence microscope (Leica, Mannheim, Germany), apoptotic cells were eventually analyzed.
Transwell assay
In serum-free medium, transfected 5-8F or CNE-1 cells were planted in the top transwell chambers (Corning Incorporated, Corning, NY, USA), which was coated with Matrigel (BD Biosciences, Franklin Lakes, NJ, USA). The bottom chambers (Corning Incorporated) were plated with medium containing 10% FBS (Gibco). Thereafter, invaded cells were fixed, stained with 1% crystal violet and eventually evaluated through an inverted microscope (magnification: 200 × ; Nikon, Tokyo, Japan).
Immunofluorescence (IF) assay
Cell samples of 5-8F and CNE-1 on culture slides were incubated for 24 h until adhered to the slides. After that, cells were washed in PBS, fixed by ice-cold methanol for 10 min and blocked in 5% BSA for 10 min. The primary antibodies against E-cadherin and N-cadherin, as well as the secondary antibodies were utilized for the incubation with cells. Following DAPI staining (0.3 mM), cells were observed using fluorescence microscope (Leica).
Western blotting
Total protein samples from 5-8F or CNE-1 cells were extracted in RIPA lysis buffer, and then separated by electrophoresis on 12% SDS-PAGE (Bio-Rad Laboratories, Hercules, CA, USA). Protein samples were then transferred onto PVDF membranes (Bio-Rad Laboratories) and incubated in 5% nonfat milk for blocking membranes. The diluted primary antibodies (1: 2000; Abcam, Cambridge, MA), including mouse monoclonal anti-E-cadherin antibody (ab76055), rabbit monoclonal anti-N-cadherin antibody (ab202030), mouse monoclonal anti-NR4A2 antibody (ab41917) and mouse monoclonal anti-GAPDH antibody (ab8245) as loading control, were used to probe membranes all night at 4 °C. Following washing in Tris-buffered saline containing 0.1% Tween-20 (TBST), the horse-radish peroxidase (HRP)-tagged rabbit monoclonal secondary antibodies (1: 5000; Abcam) against IgG were added for 2 h at room temperature. At length, the protein blots were observed using ECL detection system (Santa Cruz, CA, USA) in the dark, and then placed into gel imager, followed by analysis of Bio-Rad image analysis system (Bio-Rad). The gray values of the target proteins and the internal control were compared employing the Image J software (NIH, Bethesda, MD, USA).
Subcellular fractionation
Using the nuclear/cytoplasmic Isolation Kit (Biovision, San Francisco, CA, USA), subcellular fractionation in 5-8F or CNE-1 cells was carried out as instructed. Cells were initially lysed in the cell fractionation buffer, and centrifuged for the separation of cytosolic and nuclear fractions. The supernatant was transferred into a fresh RNase-free tube. Thereafter, the remaining lysates were rinsed in cell fractionation buffer and centrifuged. The cell disruption buffer was added for lysing cell nuclei. Lysates and the supernatant were mixed in 2 × lysis/binding solution, equal volume of ethanol was added. After washing, TRIzol reagent was added to isolate RNAs. Finally, the expression ratios of MSC-AS1 were determined by RT-qPCR, with U6 and GAPDH used as the control for nuclear RNA and cytoplasmic RNA.
RNA FISH
The specific RNA FISH probe to MSC-AS1 was synthesized by Ribobio Company. Cells of CNE-1 and 5-8F were fixed by 4% formalin, treated with protease K at 37 °C, and then rinsed in PBS. Cells were dehydrated in ethanol. 20 μl of hybridization solution containing 2 μl of probe and 18 μl of pre–hybridization solution was prepared to incubate with cells all night at 42 °C. Afterwards, cells were rinsed twice in 25% formamide/2 × saline sodium citrate (SSC). DAPI solution (0.3 mM) was then added for nuclear counter-staining. Samples were observed under fluorescence microscope.
Microarray
54 miRNAs potentially bound to MSC-AS1 were obtained from starBase. The expressions of 54 miRNAs were detected by PCR in three pairs of adjacent normal tissues and NPC tissues. Differentially expressed miRNAs (P < 0.05 and fold change > 2.0) were picked for follow-up analyses, among which miR-524-5p was most significantly down-regulated.
RNA immunoprecipitation (RIP) Assay
Using a Magna RIP™ RNA Binding Protein Immunoprecipitation Kit (Millipore, Bedford, MA, USA), RIP assay was carried out. After being harvested, transfected 5-8F or CNE-1 cells were lysed in RIP lysis buffer (Solarbio, Beijing, China). Subsequently, magnetic beads (Invitrogen) were added to the RIP lysis buffer (Solarbio) and then conjugated overnight with anti-Ago2 (Abcam) or anti-IgG (Abcam) at 4 °C. The immunoprecipitated RNA was acquired after digestion with proteinase K (Absin, Shanghai, China) and quantified by RT-qPCR.
Dual-luciferase reporter assay
The wild-type or mutant binding sequence of miR-524-5p in MSC-AS1 or NR4A2 3′-UTR was synthesized and sub-cloned into pmirGLO dual-luciferase vector (Promega, Madison, WI, USA). MSC-AS1-Wt/Mut vector or NR4A2-Wt/Mut vector was co-transfected with NC mimic or miR-524-5p mimic into 5-8F, CNE-1 or 293T cells. 48 h later, the Dual Luciferase Report Assay System (Promega) was employed to monitor luciferase activity.
RNA pull‐down assay
MiR-524-5p no-biotin probe and miR-524-5p biotin probe were synthesized by Thermo Fisher Scientific. The biotinylated miRNA was incubated with cell lysates (Invitrogen) overnight, followed by adding streptavidin magnetic beads (Invitrogen). Finally, RT-qPCR was used to detect the expression levels.
Statistical analysis
Data was expressed as mean ± SD. In order to analyze data, SPSS 20.0 software (SPSS Inc., Chicago, IL, USA) was adopted. With the use of Student’s t test or one-way ANOVA, group difference was estimated. Besides, P < 0.05 was defined to be statistically significant. All experiments were repeated at least three times. Correlation among NR4A2, MSC-AS1 and miR-524-5p was analyzed via Pearson’s correlation coefficient analysis.
Discussion
The development of NPC was known as a multistep process involving diverse external and internal factors [
36]. Evidence has proved that expression alteration of certain lncRNAs is closely correlated with the initiation and development of NPC [
37]. Previous reports have uncovered multiple lncRNAs that participate in NPC, regulating cell growth, apoptosis, migration and invasion [
7,
8]. Formerly, it was confirmed that high expression of MSC-AS1 indicated low recurrence-free survival of HCC [
9], indicating that MSC-AS1 might function as an oncogene in human cancer development. Herein, we found that MSC-AS1 level was upregulated in NPC tissues and cells. Functionally, MSC-AS1 enhanced proliferation, restrained apoptosis, induced invasion and EMT in NPC cells. These findings indicated that MSC-AS1 exerted oncogenic effect in NPC.
Mechanistically, the lncRNA-miRNA-mRNA interaction, which is recognized as ceRNA network, has been widely reported in NPC progression [
17,
18]. Herein, we found 54 candidate miRNAs that could be the downstream genes of MSC-AS1. Among which, miR-524-5p was the most significantly downregulated miRNA in NPC, indicating its high potential of association with NPC tissues. Previously, miR-524-5p has been confirmed as a tumor-suppressor in multiple cancers, such as pituitary tumor [
19], gastric cancer [
20], melanoma [
21] and glioma [
22]. Accordantly, we confirmed that miR-524-5p was downregulated in NPC tissues and cells, and that MSC-AS1 sponged miR-524-5p in NPC. These indicated that miR-524-5p was an anti-oncogene in NPC.
Moreover, we identified that NR4A2 was a downstream target of miR-524-5p. As a member of NR4A family [
23], NR4A2 has been documented as a carcinogene in multiple cancers [
28‐
30]. For example, high NR4A2 expression predicted poor prognosis and promoted chemo-resistance in squamous cell carcinoma (SCC) and colorectal cancer [
38,
39]. Also, a former study revealed that upregulation of NR4A2 contributed to poor prognosis in NPC [
30]. Concordantly, current study showed that NR4A2 was highly expressed in NPC tissues and cells, and confirmed the interaction between miR-524-5p and NR4A2. Furthermore, it was indicated that MSC-AS1 upregulated NR4A2 through sponging miR-524-5p. Finally, it was found that NR4A2 upregulation rescued the inhibitory proliferation, invasion, EMT and induced apoptosis in MSC-AS1 silenced NPC cells. All above data indicated that MSC-AS1 facilitated NPC progression in NR4A2-dependent way.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.